Identification and characterization of novel vesicular organelle appearing hyperlipidemic human macrophages

高脂血症人巨噬细胞中新型囊泡细胞器的鉴定和表征

基本信息

  • 批准号:
    17390115
  • 负责人:
  • 金额:
    $ 9.47万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2007
  • 项目状态:
    已结题

项目摘要

The macrophages under hyperlipidemic condition continuously internalize modified low density lipoprotein (LDL) and transformed to lipid laden (foamy transformed) macrophages in the arterial wall. These lipid-laden macrophages promote atherosclerosis via producing various chemokines and cytokines, therefore, mechanism of foamy transformation of the macrophages is key issue to investigate atherogenesis. Internalized modified LDL is hydrolyzed in the LAMP2-positive hydrolytic compartment, free cholesterol derived from modified LDL is transferred to the endoplasmic reticulum (ER), ACAT1, an ER resident enzyme, esterifies cholesterol, esterified cholesterol is stored as lipid droplets, thus macrophages turn into lipid laden macrophages. We discovered foamy transformed macrophages produce ER-derived, ACAT1-positive vesicular organelle (Am J Pathol, 156:227-236, 2000). To investigate the nature of these vesicles, we analyzed lipid-laden human macrophages by means of subcellular fractionation … More assay. Most of ACAT1 appeared in middle density fractions that have negligible ACAT enzymatic activity in cholesterol poor situation, while it moved to low density fractions with significant ACAT activity. Low density fractions contained trans-Golgi network marker syntaxin 6, and immunofluorescent signals from ACAT1 and syntaxin 6 were partially colocolized in lipid-laden macrophages, not in cholesterol poor macrophages. In cholesterol-rich macrophages, purified ACAT1-positive fractions by means of immunoadsorption method using ACAT1 specific antibodies contained syntaxin 6. Since syntaxin 6 distributes trans-Golgi network as well as late endosomal components, we furtuher explored the possibility of a translocation of ACAT1 to late endosomes in cholesterol-rich macrophages. As expected, foamy transformed human macrophages produced ACAT1-positive late endosomal components and these special organelles efficiently re-esterify hydrolyzed free cholesterol. These results indicate that human macrophages produce ACAT1-positive vesicles via ER fragmentation, and these vesicles cause ACAT1 translocation to trans-Golgi network/late endosomes, resulting in effective cholesterol esterification and foamy transformation of the cholesterol-rich macrophages. Less
高脂血症状态下的巨噬细胞不断内化修饰的低密度脂蛋白(LDL),并在动脉壁上转化为载脂(泡沫转化)巨噬细胞。这些富含脂质的巨噬细胞通过产生多种趋化因子和细胞因子促进动脉粥样硬化,因此巨噬细胞泡沫转化的机制是研究动脉粥样硬化发生的关键问题。内化的修饰LDL在lamp2阳性的水解室中水解,由修饰LDL产生的游离胆固醇被转移到内质网(ER),内质网驻留酶ACAT1将胆固醇酯化,酯化后的胆固醇被储存为脂滴,从而使巨噬细胞变成脂质负载巨噬细胞。我们发现泡沫转化巨噬细胞产生er来源的acat1阳性囊泡细胞器(中华病理学杂志,156:227- 233,2000)。为了研究这些囊泡的性质,我们用亚细胞分离的方法分析了含脂的人巨噬细胞。在低胆固醇情况下,ACAT1大部分出现在ACAT酶活性可忽略的中密度馏分,而向ACAT酶活性显著的低密度馏分转移。低密度部分含有反式高尔基网络标记物syntaxin 6,来自ACAT1和syntaxin 6的免疫荧光信号在脂质负载的巨噬细胞中部分共混,而在低胆固醇巨噬细胞中不存在。在富含胆固醇的巨噬细胞中,使用含有syntaxin 6的ACAT1特异性抗体,通过免疫吸附法纯化ACAT1阳性组分。由于syntaxin 6分布反式高尔基网络和晚期内体成分,我们进一步探索了ACAT1在富含胆固醇的巨噬细胞中转位到晚期内体的可能性。正如预期的那样,泡沫转化的人巨噬细胞产生acat1阳性的晚期内体成分,这些特殊的细胞器有效地将水解的游离胆固醇重新酯化。这些结果表明,人巨噬细胞通过内质网破碎产生ACAT1阳性囊泡,这些囊泡使ACAT1易位到反式高尔基网络/晚期核内体,从而使富含胆固醇的巨噬细胞发生有效的胆固醇酯化和泡沫转化。少

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Severe congestive heart failure with cardiac liver cirrhosis 10 years a fter orthotopic liver transplantation for familial amyloidotic polyneuropathy
家族性淀粉样多发性神经病原位肝移植术后 10 年出现严重充血性心力衰竭并伴有心源性肝硬化
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ando;Y;Ueda M.;Sato T.;Bergstrom J.;Inomata Y.;Yamamoto S.;杉内 博幸;安東 由喜雄;杉内 博幸;永田 四郎;植田 光晴;Rimessi P.;Sun X.;Bergstrom J.;Ueda M.;Sato T.;Zeledon RME.;Ando Y.;Bergstrom J.;Goto T.;Ueda M.;Rimessi P.;Wakita M.;Sakashita N.
  • 通讯作者:
    Sakashita N.
Mechanism of foam cell formation of macrophages in hyperlipidemic condition: generation of an endoplasmic reticulunrderived vesicular structure.
高脂血症条件下巨噬细胞泡沫细胞形成机制:内质网衍生的囊泡结构的生成。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sakashita N;Chang CCY;Chang TY;Takeya M
  • 通讯作者:
    Takeya M
AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype
  • DOI:
    10.1369/jhc.5a6871.2006
  • 发表时间:
    2006-07-01
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Komohara, Yoshihiro;Hirahara, Junko;Takeya, Motohiro
  • 通讯作者:
    Takeya, Motohiro
MCP-1/CCR2 singnaling pathway regulates hyperoxia-induced acute lung injury via nitric oxide production.
MCP-1/CCR2 信号通路通过一氧化氮的产生调节高氧诱导的急性肺损伤。
Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction
  • DOI:
    10.1161/circulationaha.106.671198
  • 发表时间:
    2007-04-10
  • 期刊:
  • 影响因子:
    37.8
  • 作者:
    Tsujita, Kenichi;Kaikita, Koichi;Takeya, Motohiro
  • 通讯作者:
    Takeya, Motohiro
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAKASHITA Naomi其他文献

SAKASHITA Naomi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAKASHITA Naomi', 18)}}的其他基金

Approach to mechanism for post-operative pulmonary vein stenosis: experimental trials for adventitial hemorrhage-associated oxidative stress regulation
术后肺静脉狭窄的机制探讨:外膜出血相关氧化应激调节的实验试验
  • 批准号:
    26670190
  • 财政年份:
    2014
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Therapeutic strategy for Niemann-Pick disease type C focusing on induction of ACAT1-positive late endosomes
C 型尼曼匹克病的治疗策略重点是诱导 ACAT1 阳性晚期内体
  • 批准号:
    23590448
  • 财政年份:
    2011
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of the ACAT-1-positive late endosomes in cholesterol-rich macrophages
富含胆固醇的巨噬细胞中 ACAT-1 阳性晚期内体的功能分析
  • 批准号:
    20590384
  • 财政年份:
    2008
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

PDLIM3-Cholesterol-SMO轴调控SHH通路激活及其在髓母细胞瘤中的功能研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
以促内涵体逃逸聚合物PEG-P[Asp(TEP)]-cholesterol为载体构建双级脑靶向基因传递系统沉默BACE1基因的研究
  • 批准号:
    81302714
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The role of cholesterol biosynthesis in CAF for tumorigenesis
CAF 中胆固醇生物合成对肿瘤发生的作用
  • 批准号:
    23K14585
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Reducing the production of toxic Abeta peptides in Alzheimer's disease by mutating the APP cholesterol-binding site: a new therapeutic strategy?
通过突变 APP 胆固醇结合位点来减少阿尔茨海默病中有毒 Abeta 肽的产生:一种新的治疗策略?
  • 批准号:
    MR/Y013859/1
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Research Grant
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
  • 批准号:
    10733720
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
用于治疗胰腺炎的降胆固醇药物:验证具有临床意义的新型治疗靶点和方法
  • 批准号:
    10585773
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Cholesterol homeostasis in the vertebrate retina
脊椎动物视网膜中的胆固醇稳态
  • 批准号:
    10580969
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Application of New Tools for Probing the Roles of Sphingolipids and Cholesterol in Influenza Virus Infection
应用新工具探索鞘脂和胆固醇在流感病毒感染中的作用
  • 批准号:
    10678459
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Disturbed Crosstalk between Cholesterol Homeostasis and Inflammation Resolution in NASH
NASH 中胆固醇稳态与炎症消退之间的干扰串扰
  • 批准号:
    10568478
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
Understanding of cholesterol transporter mechanisms via HS-AFM and computational modeling
通过 HS-AFM 和计算模型了解胆固醇转运机制
  • 批准号:
    22KF0153
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Healthy Heart Remnant Cholesterol Tackles Diabetes in Youth
健康的心脏残余胆固醇可治疗青少年糖尿病
  • 批准号:
    499350
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
    Salary Programs
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
以前列腺癌为模型的强化降胆固醇干预和抗肿瘤免疫
  • 批准号:
    10802975
  • 财政年份:
    2023
  • 资助金额:
    $ 9.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了